Lazard Capital Starts Aratana Therapeutics (PETX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
William Blair Starts Aratana Therapeutics (PETX) at Outperform
July 23, 2013 7:27 AM EDTWilliam Blair initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with an Outperform.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $10.12 yesterday, with a 52 week range of $6.56-$10.32.... More
JMP Securities Starts Aratana Therapeutics (PETX) at Market Outperform
July 22, 2013 9:01 AM EDTJMP Securities initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Market Outperform. PT $16.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
Craig-Hallum Starts Aratana Therapeutics (PETX) at Buy
July 22, 2013 9:00 AM EDTCraig-Hallum initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $15.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
Stifel Nicolaus Starts Aratana Therapeutics (PETX) at Buy
July 22, 2013 8:33 AM EDTStifel Nicolaus initiates coverage on Aratana Therapeutics (NASDAQ: PETX) with a Buy. PT $13.00.
For an analyst ratings summary and ratings history on Aratana Therapeutics click here. For more ratings news on Aratana Therapeutics click here.
Shares of Aratana Therapeutics closed at $9.57 yesterday, with a 52 week range of $6.56-$10.32.... More
